|
|
48420 Avalon Heights
Fremont, CA 94539 USA
phone:(510)--299-9066
fax:
|
|
| Symbol |
Private |
| Founded |
2008 |
| Employees |
|
|
|
| www.endurancerhythm.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Developing technology that powers implantable devices using energy from the beating heart |
|
| Management |
| Bob Larson, CEO |
| |
|
|
| |
|
| Keywords |
| CRM, cardiac rhythm management, microgenerator, cardiology, surgery |
|
|
|
| Description |
|
Endurance Rhythm is an early-stage company targeting two critical unmet needs in the huge cardiac rhythm management (CRM) market: short battery life that leads to costly and risky re-operations, and devices that are bulkier and more costly than is necessary. |
|
| Products / Services |
Endurance Rhythm has designed and patented a micro-generator that harnesses kinetic
energy from the heart to power electronic implants.
|
|
| Technology / Differentiation |
| Endurance Rhythm's proprietary microgenerator technology uses the kinetic energy of the beating heart to generate electrical power to drive implantable cardiac rhythm management devices. |
|
| Market / Customers |
The company believes its technology will be attractive to all current manufacturers of CRM devices in the competitive $10 billion U.S. market as well as worldwide. Every year, ~15% of all implantable cardioverter defibrillator (ICD) and pacemaker surgeries are for replacements of devices whose batteries have failed (rendering the devices unusable). The Endurance Rhythm generator technology will greatly extend device life, decreasing costs and the need for repeat surgeries.
|
|
| Competitors / Substitutes / Alternatives |
Competition among makers of electronic medical implants is intense, and the pressure
to differentiate products has led to decreased size and new power-hungry features. As a result, most of the 550,000 Implantable Cardiac Defibrillators (ICDs) and pacemakers placed each year inevitably fail due to limited battery life. The majority of patients who receive these implants will outlive their devices and require replacements. Replacement surgeries are not only costly - they also have complication rates up to three times higher than those of the initial implantation procedure. Endurance Rhythm's proprietary technology fills the need for longer-lasting medical implants, as well as helping to reduce the size of these devices.
|
|
| Strategy |
Endurance Rhythm was created to develop and commercialize this innovation, created
at Stanford University. We are seeking $1.5M in funding to refine, test, and optimize an
advanced at-scale model, engage partners, expand IP coverage, and optimize the
business scenarios. The design is simple, fills an unmet need in large and growing
markets ($10 billion/yr, where 1% market share translates to $100M in revenues), and
benefits patients, physicians, payers, and device manufacturers. Large ICD/pacemaker
manufacturers have already expressed significant interest in the technology. Following
proof of concept, Endurance Rhythm will be well positioned for an early acquisition, or to pursue multiple longer-term partnering opportunities in multiple markets, including ICDs, pacemakers, and neuro- and GI pacer devices.
|
|
| Status |
| The company has developed a successful early prototype of its microgenerator. Within 18 months, the company plans to develop an optimized proof of principle design and begin animal testing. Endurance Rhythm is currently seeking $1.5 million in funding to refine, test, and optimize an advanced at-scale model, engage potential partners, and complete proof of principle studies. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members